Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0031350 (
pharyngitis
)
2,405
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The pharynx is the primary reservoir for strains of group A STREPTOCOCCUS: (GAS) associated both with
pharyngitis
(streptococcal sore throat) and with invasive or "flesh-eating" soft tissue infections. We now report that
CD44
, a hyaluronic acid-binding protein that mediates human cell-cell- and cell-extracellular matrix-binding interactions, functions as a receptor for GAS colonization of the pharynx in vivo. We found that attachment of GAS to murine epithelial keratinocytes was mediated by binding of the GAS hyaluronic acid capsular polysaccharide to
CD44
. In studies of transgenic mice with a selective defect in epithelial expression of
CD44
, GAS adherence to
CD44
-deficient keratinocytes in vitro was reduced compared with adherence to keratinocytes expressing normal levels of
CD44
. After intranasal inoculation, GAS colonized the oropharynx of wild-type mice but failed to colonize transgenic mice deficient in
CD44
expression. GAS colonization of wild-type mice could be blocked by coadministration of mAb to
CD44
or by pretreatment of the animals with exogenous hyaluronic acid. These results provide evidence that
CD44
serves as a receptor for GAS colonization of the pharynx and support the potential efficacy of disrupting the interaction between the GAS hyaluronic acid capsule and
CD44
as a novel approach to preventing pharyngeal infection.
...
PMID:CD44 as a receptor for colonization of the pharynx by group A Streptococcus. 1103 59